Larimar Therapeutics (LRMR) Q1 2025 Earnings
LRMR·Reported April 30, 2025·Before market open
Diluted EPS came in at $-0.46 (-70.4% YoY), missed the $-0.42 consensus by $0.04.
Diluted EPS
$-0.46missed by $0.04
Consensus: $-0.42
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Larimar Therapeutics's Q1 2025 earnings report.
Larimar Therapeutics (LRMR) reported Q1 2025 earnings on April 30, 2025 before market open.
Larimar Therapeutics reported diluted EPS of $-0.46 for Q1 2025.
EPS missed the consensus estimate of $-0.42 by $0.04.
Compared to the same quarter a year prior, diluted EPS declined 70.4% from $-0.27.
You can read the 10-Q periodic report (0000950170-25-061222) directly on SEC EDGAR. The filing index links above go to sec.gov.